09:58 AM EDT, 10/28/2024 (MT Newswires) -- Eli Lilly ( LLY ) has entered into a multi-year collaboration with ViaNautis Bio to develop targeted genetic nanomedicines utilizing ViaNautis' polyNaut technology, ViaNautis said Monday.

As part of the deal, ViaNautis said it will receive an upfront payment, with potential for additional research milestones and royalties linked to clinical and commercial advancements of specific products.

Price: 893.72, Change: +1.02, Percent Change: +0.11